Literature DB >> 8709974

Platelet calcium pump activity in essential hypertensives and their first-degree relatives.

S Gulati1, M Khullar, B K Sharma, N K Ganguly.   

Abstract

Intracellular free Ca2+ concentration has been shown to be elevated in platelets of patients with essential hypertension. This study was designed to characterize Ca(2+)-pump activity of the platelet membranes (surface and intracellular) in these patients A double-blind study was carried out. Untreated and treated (on beta-blockers) essential hypertensives were studied in comparison with normotensive control subjects. First degree blood relatives of essential hypertensives were also studied. The Ca2+ activation kinetics of the enzyme showed a significant decrease in the Vmax (for the plasma- and intracellular membranes) and Km (for the intracellular membranes) in the essential hypertensive patients. Increased platelet membrane cholesterol content was observed in these patients. Lowered Ca2(+)-efflux by Ca2(+)-ATPase may lead to elevated intracellular free Ca2(+)-levels in platelet of essential hypertensives. A lowered Ca2(+) -ATPase activity may emerge as a marker for essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709974     DOI: 10.1007/BF00239317

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

2.  Further characterization of the plasma membrane- and intracellular membrane-associated platelet Ca2+ transport systems.

Authors:  J Enouf; R Bredoux; N Bourdeau; B Sarkadi; S Levy-Toledano
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.

Authors:  P Erne; P Bolli; E Bürgisser; F R Bühler
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

4.  Stereospecific modulation of the calcium channel in human erythrocytes by cholesterol and its oxidized derivatives.

Authors:  L Neyses; R Locher; M Stimpel; R Streuli; W Vetter
Journal:  Biochem J       Date:  1985-04-01       Impact factor: 3.857

5.  Abnormal aggregation accompanies abnormal platelet Ca2+ handling in arterial thrombosis.

Authors:  N M Shanbaky; Y Ahn; W Jy; W Harrington; L Fernandez; D H Haynes
Journal:  Thromb Haemost       Date:  1987-02-03       Impact factor: 5.249

6.  Platelet cytosolic proton and free calcium concentrations in essential hypertension.

Authors:  C Astarie; J Levenson; A Simon; P Meyer; M A Devynck
Journal:  J Hypertens       Date:  1989-06       Impact factor: 4.844

7.  Increased platelet calcium in thrombosis and related disorders and its correction by nifedipine.

Authors:  Y S Ahn; W Jy; W J Harrington; N Shanbaky; L F Fernandez; D H Haynes
Journal:  Thromb Res       Date:  1987-01-15       Impact factor: 3.944

8.  Platelet calcium transport in hypertension.

Authors:  W L Dean; J E Pope; M E Brier; G R Aronoff
Journal:  Hypertension       Date:  1994-01       Impact factor: 10.190

9.  Platelet calcium and quenched-flow aggregation kinetics in essential hypertension.

Authors:  M A Taylor; C R Ayers; A R Gear
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

10.  Cytoplasmic free [Ca2+] is increased in the platelets of spontaneously hypertensive rats and essential hypertensive patients.

Authors:  G Bruschi; M E Bruschi; M Caroppo; G Orlandini; M Spaggiari; A Cavatorta
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

View more
  1 in total

1.  Glycine reduces platelet aggregation.

Authors:  Peter Schemmer; Zhi Zhong; Uwe Galli; Michael D Wheeler; Li Xiangli; Blair U Bradford; Lars O Conzelmann; Dow Forman; José Boyer; Ronald G Thurman
Journal:  Amino Acids       Date:  2012-11-08       Impact factor: 3.520

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.